Cargando…
Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)
Natural killer T cell lymphoma (NKTL) is an aggressive disease with very poor treatment outcomes in the advanced stages. With chemotherapy, initial response rates to treatment are high but responses are short lived. A better understanding of the complex molecular pathogenesis of this disease is esse...
Autores principales: | Somasundaram, Nagavalli, Lim, Jing Quan, Ong, Choon Kiat, Lim, Soon Thye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420729/ https://www.ncbi.nlm.nih.gov/pubmed/30876435 http://dx.doi.org/10.1186/s13045-019-0717-6 |
Ejemplares similares
-
Towards Next Generation Biomarkers in Natural Killer/T-Cell Lymphoma
por: Chan, Jason Yongsheng, et al.
Publicado: (2021) -
Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma
por: Yap, Daniel Ren Yi, et al.
Publicado: (2023) -
Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations
por: Chan, Jason Yongsheng, et al.
Publicado: (2023) -
A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter study
por: Tan, Khee Ming, et al.
Publicado: (2019) -
Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma
por: Zhou, Jianbiao, et al.
Publicado: (2023)